膠體金法檢測(cè)瘧疾測(cè)試紙

廣州健侖生物科技有限公司

（廣州健侖生物科技有限公司是集研制開(kāi)發(fā)、銷售、服務(wù)于一體的優(yōu)良企業(yè),公司產(chǎn)品涉及臨床快速診斷試劑、食品安全檢測(cè)試劑，違禁品快速檢測(cè)，動(dòng)物疾病防疫檢測(cè)試劑，免疫診斷試劑、臨床血液學(xué)和體液學(xué)檢驗(yàn)試劑、微生物檢驗(yàn)試劑、分子生物學(xué)檢驗(yàn)試劑、臨床生化試劑、有機(jī)試劑等眾多領(lǐng)域，同時(shí)核心代理Panbio、FOCUS、Qiagen、IBL、CORTEZ、Fuller、Inbios、BinaxNOW、LumuQuick、日本富士、日本生研等多家有名診斷產(chǎn)品集團(tuán)公司產(chǎn)品，致力于為商檢單位、疾病預(yù)防控制中心、海關(guān)出入境檢疫局、衛(wèi)生防疫單位,緝毒系統(tǒng)，戒毒中心，檢驗(yàn)檢疫單位、生化企業(yè)、科研院所、醫(yī)療機(jī)構(gòu)等機(jī)構(gòu)與行業(yè)提供*、高品質(zhì)的產(chǎn)品服務(wù)。此外，本公司還開(kāi)展食品、衛(wèi)生、環(huán)境、藥品等多方面的第三方檢測(cè)服務(wù)。）

膠體金法檢測(cè)瘧疾測(cè)試紙 

本試劑盒主要是采用膠體金層析的原理制成，用于檢測(cè)人體血清/血漿/全血標(biāo)本中，感染的瘧原蟲抗體，包括了惡性瘧原蟲和間日瘧原蟲、卵形瘧原蟲、三日瘧原蟲共有抗原的鑒別性檢測(cè)。

【病原學(xué)檢測(cè)】

瘧疾檢測(cè),用于檢測(cè)出虐疾的病原體——瘧原蟲，是明確診斷的zui直接證據(jù)。目前常用的層析法，具有操作簡(jiǎn)單、靈敏度高和可鑒別蟲種等優(yōu)點(diǎn)，廣泛用于瘧疾的病原學(xué)診斷，是目前zui常用的方法之一。

瘧疾（Malaria）經(jīng)按蚊叮咬而感染瘧原蟲所引起的蟲媒傳染病。臨床以周期性寒戰(zhàn)、發(fā)熱、頭痛、出汗和貧血、脾腫大為特征。兒童發(fā)病率高，大都于夏秋季節(jié)流行。瘧原蟲寄生于人體所引起的傳染病。經(jīng)瘧蚊叮咬或輸入帶瘧原蟲者的血液而感染。不同的瘧原蟲分別引起間日瘧、三日瘧、惡性瘧及卵圓瘧。本病主要表現(xiàn)為周期性規(guī)律發(fā)作，全身發(fā)冷、發(fā)熱、多汗，長(zhǎng)期多次發(fā)作后，可引起貧血和脾腫大。瘧疾是由瘧原蟲引起的寄生蟲病，于夏秋季發(fā)病較多。在熱帶及亞熱帶地區(qū)一年四季都可以發(fā)病，并且容易流行。

瘧疾（Malaria）經(jīng)按蚊叮咬而感染瘧原蟲所引起的蟲媒傳染病。臨床以周期性寒戰(zhàn)、發(fā)熱、頭痛、出汗和貧血、脾腫大為特征。兒童發(fā)病率高，大都于夏秋季節(jié)流行。瘧原蟲寄生于人體所引起的傳染病。經(jīng)瘧蚊叮咬或輸入帶瘧原蟲者的血液而感染。不同的瘧原蟲分別引起間日瘧、三日瘧、惡性瘧及卵圓瘧。本病主要表現(xiàn)為周期性規(guī)律發(fā)作，全身發(fā)冷、發(fā)熱、多汗，長(zhǎng)期多次發(fā)作后，可引起貧血和脾腫大。瘧疾是由瘧原蟲引起的寄生蟲病，于夏秋季發(fā)病較多。在熱帶及亞熱帶地區(qū)一年四季都可以發(fā)病，并且容易流行。

中國(guó)解放前，每年至少有3000萬(wàn)以上瘧疾病人，病死率約為1％。解放后在1954年、1960年和1970年曾發(fā)生三次大范圍的瘧疾暴發(fā)流行，對(duì)工農(nóng)業(yè)生產(chǎn)和人民身體健康造成巨大危害。經(jīng)過(guò)多年的積極防治，近幾年瘧疾發(fā)病人數(shù)已控制在20萬(wàn)－30萬(wàn)例。中國(guó)常見(jiàn)的是間日瘧，惡性瘧主要流行于海南、云南二省，其余各省有少數(shù)輸入病例，三日瘧和卵形瘧已罕見(jiàn)。中國(guó)的瘧區(qū)大多分布在海拔1500米以下地帶；北緯33度以北地區(qū)傳播發(fā)生在7月至11月間，北緯33度至北緯25度間地區(qū)傳播發(fā)生在5月至12月間，北緯25度以南地區(qū)全年均有傳播發(fā)生。黑龍江、吉林、內(nèi)蒙、甘肅、北京、寧夏、青海、新疆（除伊犁河谷地帶）以及西藏（除雅魯藏布江河谷的zui東南端）目前已不存在瘧疾流行的危險(xiǎn)性。
 
在熱帶和亞熱帶國(guó)家與地區(qū)，瘧疾流行仍很嚴(yán)重。非洲撒哈拉沙漠以南地區(qū)、中南美洲、印度次大陸、東南亞以及太平洋島國(guó)地區(qū)尤甚，每年發(fā)病人數(shù)約1.5億－2億，死亡人數(shù)約150萬(wàn)－270萬(wàn)。抗氯喹惡性瘧原蟲廣泛存在于熱帶地區(qū)，特別是亞馬遜地區(qū)和東南亞國(guó)家?？孤揉g日瘧原蟲存在于巴布亞－新幾內(nèi)亞、瓦努阿圖，印度尼西亞和緬甸的部分地區(qū)也有報(bào)告。

我司為美國(guó)NOVABIOS公司在中國(guó)地區(qū)戰(zhàn)略合作伙伴，負(fù)責(zé)該公司產(chǎn)品的總經(jīng)銷及售后服務(wù)工作。還與各疾控中心，疾病防御中心有合作關(guān)系，例如中國(guó)疾病預(yù)防控制中心 、浙江省疾病預(yù)防控制中心  ，詳情可以我司工作人員。

（  MOB：楊永漢）  

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

想了解更多的產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103

Malaria (Malaria) Infestation with parasites caused by parasites of Anopheles mosquitoes. Clinical periodic chills, fever, headache, sweating and anemia, splenomegaly is characterized. The high incidence of children, most popular in summer and autumn. Plasmodium parasitic on the human body caused by infectious diseases. Infected by malaria mosquito bites or by blood entering malaria parasites. Different Plasmodium species cause P. vivax, P. vivax, P. falciparum and P. ovale, respectively. The disease is mainly characterized by periodic regular seizures, systemic chills, fever, and hyperhidrosis. After a long period of multiple episodes, it can cause anemia and splenomegaly. Malaria is a parasitic disease caused by Plasmodium, which is more common in summer and autumn. In the tropics and subtropics, it can develop in all seasons and it is easy to spread.
Malaria (Malaria) Infestation with parasites caused by parasites of Anopheles mosquitoes. Clinical periodic chills, fever, headache, sweating and anemia, splenomegaly is characterized. The high incidence of children, most popular in summer and autumn. Plasmodium parasitic on the human body caused by infectious diseases. Infected by malaria mosquito bites or by blood entering malaria parasites. Different Plasmodium species cause P. vivax, P. vivax, P. falciparum and P. ovale, respectively. The disease is mainly characterized by periodic regular seizures, systemic chills, fever, and hyperhidrosis. After a long period of multiple episodes, it can cause anemia and splenomegaly. Malaria is a parasitic disease caused by Plasmodium, which is more common in summer and autumn. In the tropics and subtropics, it can develop in all seasons and it is easy to spread.

Before the liberation of China, there were at least 30 million malaria patients each year with a case fatality rate of about 1%. After the liberation, three large-scale malaria outbreaks occurred in 1954, 1960, and 1970, which caused great harm to industrial and agricultural production and people's health. After years of active prevention and control, the number of malaria cases in recent years has been controlled at 200,000 to 300,000. The most common form of P. vivax in China is P. falciparum. Plasmodium falciparum is prevalent in Hainan and Yunnan Provinces. There are a few imported cases in the remaining provinces. Malaria and oval malaria are rare on the third day. Most of the malaria endemic areas in China are located at an altitude of 1,500 meters below sea level. In the area north of 33 degrees north latitude, the spread occurs between July and November. Between 33 degrees north latitude and 25 degrees north latitude, the spread occurs between May and December. Latitude 25 Degree south of the year have occurred throughout the year. Heilongjiang, Jilin, Inner Mongolia, Gansu, Beijing, Ningxia, Qinghai and Xinjiang (except the Ili Valley) and Tibet (the most southeastern tip of the Yarlung Zangbo Valley) no longer have the malaria epidemic.
 
In tropical and sub-tropical countries and areas, the malaria epidemic is still very serious. Especially in sub-Saharan Africa, Central and South America, the Indian subcontinent, Southeast Asia and the Pacific island countries, the number of cases in the world is about 150 million to 200 million and the death toll is about 1.5 million to 2.7 million. Resistant to chloroquine Plasmodium falciparum widespread in the tropics, especially in the Amazon and Southeast Asian countries. Anti-chloroquine P. vivax is also reported in parts of Papua New Guinea, Vanuatu, Indonesia and Myanmar.